Ketomag

Ketoprofen, the active ingredient in Ketomag, is a nonsteroidal anti-inflammatory drug presented as a topical formulation for external use. It is used to relieve pain and reduce inflammation in musculoskeletal conditions and other localized discomforts.

GNH USA supplies Ketomag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen acts locally on inflammatory pathways to manage pain and swelling in several musculoskeletal conditions.

Rheumatoid arthritis: reduces joint pain and swelling. Osteoarthritis: alleviates chronic joint discomfort and improves mobility. Acute musculoskeletal injury: decreases inflammation and associated pain.

Ketomag may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation or burning sensation at the application site. - Redness or erythema. - Itching or pruritus. - Dry or flaky skin. - Mild rash. - Localized swelling.

Serious or Rare Side Effects: - Severe allergic reactions such as angioedema or anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Significant skin necrosis or ulceration. - Systemic toxicity leading to hepatic injury. - Acute renal impairment. - Gastrointestinal bleeding when absorbed systemically.

When using Ketomag, consider the following safety measures.

Assess renal function: adjust use in patients with renal impairment. Avoid in known hypersensitivity: discontinue if allergic reaction occurs. Use with caution in elderly: increased risk of gastrointestinal effects. Limit concurrent NSAID use: higher risk of bleeding and ulceration. Avoid application on broken skin: may increase systemic absorption. Store at room temperature: keep in the original container, protect from moisture and light.

Ketomag can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Selective COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: potential elevation of lithium serum levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may reduce renal function when combined. - Diuretics: heightened risk of renal impairment. - Methotrexate: possible increase in methotrexate toxicity.